References
Zhang, H., Jing, L., Zhai, C., Xiang, Q., Tian, H. and Hu, H. (2022) Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease. Journal of Cardiovascular Pharmacology, 81, 175-182. >https://doi.org/10.1097/fjc.0000000000001387
McManus, D.D., Gore, J., Yarzebski, J., Spencer, F., Lessard, D. and Goldberg, R.J. (2011) Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI. The American Journal of Medicine, 124, 40-47. >https://doi.org/10.1016/j.amjmed.2010.07.023
Du, J., Wu, W., Zhu, B., Tao, W., Liu, L., Cheng, X., et al. (2023) Recent Advances in Regulating Lipid Metabolism to Prevent Coronary Heart Disease. Chemistry and Physics of Lipids, 255, Article ID: 105325. >https://doi.org/10.1016/j.chemphyslip.2023.105325
Li, K., Yang, X., Wang, L., Chen, M., Zhao, W., Xu, L., et al. (2016) Modification of the Association between Smoking Status and Severity of Coronary Stenosis by Vitamin D in Patients Suspected of Coronary Heart Disease. Medicine, 95, e4817. >https://doi.org/10.1097/md.0000000000004817
曲政, 尤斌, 李平. 不同年龄段早发冠心病患者临床特征及危险因素的分析[J]. 心肺血管病杂志, 2024, 43(5): 433-437.
Jain, V., Ghosh, R.K., Bandyopadhyay, D., Kondapaneni, M., Mondal, S., Hajra, A., et al. (2021) Serum Bilirubin and Coronary Artery Disease: Intricate Relationship, Pathophysiology, and Recent Evidence. Current Problems in Cardiology, 46, Article ID: 100431. >https://doi.org/10.1016/j.cpcardiol.2019.06.003
Leyva, F. (1998) Uric Acid in Chronic Heart Failure: A Marker of Chronic Inflammation. European Heart Journal, 19, 1814-1822. >https://doi.org/10.1053/euhj.1998.1188
Ames, B.N., Cathcart, R., Schwiers, E. and Hochstein, P. (1981) Uric Acid Provides an Antioxidant Defense in Humans against Oxidant-and Radical-Caused Aging and Cancer: A Hypothesis. Proceedings of the National Academy of Sciences of the United States of America, 78, 6858-6862. >https://doi.org/10.1073/pnas.78.11.6858
Hink, H.U., Santanam, N., Dikalov, S., McCann, L., Nguyen, A.D., Parthasarathy, S., et al. (2002) Peroxidase Properties of Extracellular Superoxide Dismutase: Role of Uric Acid in Modulating in Vivo Activity. Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1402-1408. >https://doi.org/10.1161/01.atv.0000027524.86752.02
Papezikova, I., Pekarova, M., Lojek, A., et al. (2009) The Effect of Uric Acid on Homocysteine-Induced Endothelial Dysfunction in Bovine Aortic Endothelial Cells. Neuro Endocrinology Letters, 30, 112-115.
Sedlak, T.W., Saleh, M., Higginson, D.S., Paul, B.D., Juluri, K.R. and Snyder, S.H. (2009) Bilirubin and Glutathione Have Complementary Antioxidant and Cytoprotective Roles. Proceedings of the National Academy of Sciences of the United States of America, 106, 5171-5176. >https://doi.org/10.1073/pnas.0813132106
Samb, A., Taillé, C., Almolki, A., Mégret, J., Staddon, J.M., Aubier, M., et al. (2002) Heme Oxygenase Modulates Oxidant-Signaled Airway Smooth Muscle Contractility: Role of Bilirubin. American Journal of Physiology-Lung Cellular and Molecular Physiology, 283, L596-L603. >https://doi.org/10.1152/ajplung.00446.2001
Öllinger, R., Bilban, M., Erat, A., Froio, A., McDaid, J., Tyagi, S., et al. (2005) Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation. Circulation, 112, 1030-1039. >https://doi.org/10.1161/circulationaha.104.528802
Greabu, M., Olinescu, R., Kummerow, F.A. and Crocnan, D.O. (2001) The Levels of Bilirubin May Be Related to an Inflammatory Condition in Patients with Coronary Heart Disease. Acta Poloniae Pharmaceutica, 58, 225-231.
Hwang, H., Lee, S. and Kim, S. (2011) Relationship between Bilirubin and C-Reactive Protein. Clinical Chemistry and Laboratory Medicine, 49, 1823-1828. >https://doi.org/10.1515/cclm.2011.662
Ghem, C., Sarmento-Leite, R.E., de Quadros, A.S., Rossetto, S. and Gottschall, C.A.M. (2010) Serum Bilirubin Concentration in Patients with an Established Coronary Artery Disease. International Heart Journal, 51, 86-91. >https://doi.org/10.1536/ihj.51.86
李鲁, 张迪, 杨淑彬. 血清胆红素、尿酸联合同型半胱氨酸检测对冠心病的诊断价值[J]. 陕西医学杂志, 2022, 51(12): 1589-1592.
Xiao, J., Lu, Y. and Yang, X. (2020) Ultrasound Detection of Epicardial Adipose Tissue Combined with Ischemic Modified Albumin in the Diagnosis of Coronary Heart Disease. The Heart Surgery Forum, 23, E461-E464. >https://doi.org/10.1532/hsf.3015
Villelabeitia-Jaureguizar, K., Vicente-Campos, D., Berenguel Senen, A., Hernández Jiménez, V., Ruiz Bautista, L., Barrios Garrido-Lestache, M.E. and López Chicharro, J. (2019) Mechanical Efficiency of High versus Moderate Intensity Aerobic Exercise in Coronary Heart Disease Patients: A Randomized Clinical Trial. Cardiology Journal, 26, 130-137.
Oda, E. and Kawai, R. (2011) A Possible Cross-Sectional Association of Serum Total Bilirubin with Coronary Heart Disease and Stroke in a Japanese Health Screening Population. Heart and Vessels, 27, 29-36. >https://doi.org/10.1007/s00380-011-0123-7
Gupta, N., Singh, T., Chaudhary, R., Garg, S.K., Sandhu, G.S., Mittal, V., et al. (2016) Bilirubin in Coronary Artery Disease: Cytotoxic or Protective? World Journal of Gastrointestinal Pharmacology and Therapeutics, 7, 469-476. >https://doi.org/10.4292/wjgpt.v7.i4.469
Stender, S., Frikke‐Schmidt, R., Nordestgaard, B.G., Grande, P. and Tybjærg‐Hansen, A. (2012) Genetically Elevated Bilirubin and Risk of Ischaemic Heart Disease: Three Mendelian Randomization Studies and a Meta‐Analysis. Journal of Internal Medicine, 273, 59-68. >https://doi.org/10.1111/j.1365-2796.2012.02576.x
丁宁, 陈长强, 樊绮诗. 红细胞分布宽度、血清总胆红素与冠心病及冠状动脉病变程度相关性研究[J]. 检验医学, 2019, 34(10): 889-893.
李姗茜. 冠状动脉病变程度与血清胆红素水平、炎性指标的相关性研究[D]: [硕士学位论文]. 洛阳: 河南科技大学, 2018.
崔妍. 纤维蛋白原、脂蛋白a、胆红素等因素与冠脉病变程度的关系[D]: [硕士学位论文]. 长春: 吉林大学, 2016.
Akboga, M.K., Canpolat, U., Sahinarslan, A., Alsancak, Y., Nurkoc, S., Aras, D., et al. (2015) Association of Serum Total Bilirubin Level with Severity of Coronary Atherosclerosis Is Linked to Systemic Inflammation. Atherosclerosis, 240, 110-114. >https://doi.org/10.1016/j.atherosclerosis.2015.02.051
Turfan, M., Duran, M., Poyraz, F., Yayla, C., Akboga, M.K., Sahinarslan, A., et al. (2013) Inverse Relationship between Serum Total Bilirubin Levels and Severity of Disease in Patients with Stable Coronary Artery Disease. Coronary Artery Disease, 24, 29-32. >https://doi.org/10.1097/mca.0b013e32835b0c13
Sahin, O., Akpek, M., Elcik, D., Karadavut, S., Simsek, V., Tulmac, M., et al. (2012) Bilirubin Levels and the Burden of Coronary Atherosclerosis in Patients with STEMI. Angiology, 64, 200-204. >https://doi.org/10.1177/0003319712440619
Kaya, M.G., Sahin, O., Akpek, M., Duran, M., Uysal, O.K., Karadavut, S., et al. (2013) Relation between Serum Total Bilirubin Levels and Severity of Coronary Artery Disease in Patients with Non-St-Segment Elevation Myocardial Infarction. Angiology, 65, 245-249. >https://doi.org/10.1177/0003319713504820
Canpolat, U., Aytemir, K., Yorgun, H., Hazırolan, T., Kaya, E.B., Şahiner, L., et al. (2013) Association of Serum Total Bilirubin Levels with the Severity, Extent and Subtypes of Coronary Atherosclerotic Plaques Detected by Coronary CT Angiography. The International Journal of Cardiovascular Imaging, 29, 1371-1379. >https://doi.org/10.1007/s10554-013-0209-7
Zhu, K., Wang, Y., Wang, Y. and Wang, N. (2016) The Relationship between Serum Levels of Total Bilirubin and Coronary Plaque Vulnerability. Coronary Artery Disease, 27, 52-58. >https://doi.org/10.1097/mca.0000000000000309
Xu, C., Dong, M., Deng, Y., Zhang, L., Deng, F., Zhou, J., et al. (2019) Relation of Direct, Indirect, and Total Bilirubin to Adverse Long-Term Outcomes among Patients with Acute Coronary Syndrome. The American Journal of Cardiology, 123, 1244-1248. >https://doi.org/10.1016/j.amjcard.2019.01.019